Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for November 18th

Read MoreHide Full Article

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, November 18th:

Cohu, Inc. (COHU - Free Report) : This provider of semiconductor test and inspection handlers and other equipment has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

Cohu, Inc. Price and Consensus

Cohu, Inc. Price and Consensus

Cohu, Inc. price-consensus-chart | Cohu, Inc. Quote

Cohu’s shares gained 31.9% over the last one month more than S&P 500’s rise of 4.5%. The company possesses a Momentum Score of A.

Ascendis Pharma A/S (ASND - Free Report) : This clinical stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.

Ascendis Pharma’s shares gained 13.8% over the last one month. The company possesses a Momentum Score of B.

Aspen Group, Inc. (ASPU - Free Report) : This online provider of higher education services has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.3% over the last 60 days.

Aspen’s shares gained 19.6% over the last one month. The company possesses a Momentum Score of B.

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”

Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.5% per year. So be sure to give these hand-picked 7 your immediate attention.

See them now >>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Cohu, Inc. (COHU) - free report >>

Aspen Group Inc. (ASPU) - free report >>

Ascendis Pharma A/S (ASND) - free report >>

Published in